Tu ne cede malis, sed contra audentior ito

Website powered by Mises Institute donors

Mises Institute is a tax-exempt 501(c)(3) nonprofit organization. Contributions are tax-deductible to the full extent the law allows. Tax ID# 52-1263436

[embedded content]

Tags: Featured,newsletter

In response to the many shortcomings of the Soviet Union, Mao Zedong’s China, and Venezuela, the refrain, “It wasn’t real socialism,” has emerged as a rallying cry among apologists of socialism. Some readily admit the failures of these regimes and attribute the failures to capitalism rather than socialism. Some refuse to recognize the failure whatsoever; they see these experiments as genuine instances of “real socialism” and perceive them to be unequivocal successes.
How can this happen? Don’t we have mountains of evidence that these regimes were catastrophic failures? That is definitely the case, but these socialists also claim to have mountains of evidence in their favor—at least enough to catch a capitalist off guard. Most Americans have been taught their whole

Despite its origin in Marxist-syndicalist thought, “fascism” has long been used as a derogatory label for practically anyone on the right wing of the political spectrum. Sometimes the label is warranted, but other times it is used against those who have virtually nothing in common with fascists, such as libertarian capitalists. Progressives are quick to label any kind of economic deregulation and reduction in federal overreach as “fascist.”
Want to have a free market? Fascist. Want to get the federal government out of education? Fascist.
The history of projecting fascism’s crimes onto capitalism and capitalists is very long. The Communist International in 1935 declared fascism the result of monopoly capitalism. In the 1960s and ’70s, many Marxist intellectuals

Currently, 63 percent of American adults are on prescription drugs, according to a 2021 survey. Of this 63 percent of Americans, 26 percent say they have difficulty affording their prescriptions. Despite the prices of prescription drugs falling in recent years, an increasing number of Americans are concerned about high drug costs and demanding action be taken, 88 percent saying they want it to be easier for generic drugs to enter the market. The same percentage demand price controls to limit the maximum cost of drugs.
President Joe Biden recently tweeted that we should cap insulin prices at $35, and his Build Back Better Act includes provisions for the state to lower the description drug prices through “negotiations” and limits annual drug price increases.
Mark